CTRI/2017/06/008779已完成4 期
A study of anti-hypertensive drug prescription patterns and scoring of cardiovascular risk in hypertensive post-menopausal women
Govt Medical College Patiala0 个研究点目标入组 300 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Inclusion Criteria
- •1 Women with self reported cessation of menstruation for more than 12 consecutive months.
- •2PMW with surgically induced menopause.
- •3Patients with HT in stage I/ stage II.
- •4Newly diagnosed and old patients of HT.
- •5Hypertensive patients with or without comorbidities like diabetes, obesity, hypothyroidism.
- •Exclusion Criteria
- •1Women with indeterminate menopausal status.
- •2Patients with SBP > 210 and/or DBP > 120 mm Hg, requiring emergency care.
- •3Patients with CAD at present or previous history of CAD.
- •4Patients with chronic renal or hepatic disease.
排除标准
- •Women with indeterminate menopausal status.
- •Patients with SBP > 210 and/or DBP > 120 mm Hg, requiring emergency care.
- •Patients with CAD at present or previous history of CAD.
- •Patients with chronic renal or hepatic disease.
研究者
相似试验
已完成
不适用
Research for antihypertensive prescription and office blood pressure associated home blood control in Japan, and association of orthostatic blood pressure changes with antihypertensive regimens.HypertensionJPRN-UMIN000009466Japanese Medical and Dental Practitioners for the Improvement of Medical Care20,000
已完成
不适用
Clinical studies on antihypertensive drugs used for proteinuria and hypertension intended for the bevacizumab-treated patientscolorectal cancerJPRN-UMIN000034880Iwate Medical University70
尚未招募
不适用
Trin Panchmool Kwath in HypertensioCTRI/2019/11/022015Principal Rajiv Gandhi government Ayurvedic college Paprola
已完成
不适用
Clinical study on the resistance to antihypertensive therapy in patients with diabetes mellitusJPRN-UMIN000003195Komono Kosei Hospital100
已完成
不适用
pattern of use of antihypertensive agents in elderly hypertensive patients with or without concomitant diseases.CTRI/2018/06/014662DR Champakala C250
